SCHEMBL236454

SCHEMBL236454

C1C[N]CSC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3173235 0.90
SCHEMBL419287 0.88
SCHEMBL9339 0.79
SCHEMBL973276 0.79
SCHEMBL71194 0.73
SCHEMBL8076288 0.65
SCHEMBL4083 0.63
SCHEMBL27207 0.63
SCHEMBL14698201 0.63
Hydrochloric Acid SCHEMBL3262873 0.59

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 411 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3286346-A1 METHODS FOR SELECTIVE LEACHING AND EXTRACTION OF PRECIOUS METALS IN ORGANIC SOLVENTS University of Saskatchewan (CA) 2018-02-28 EP claimed
EP-2318363-A1 HETEROCYCLIC DERIVATIVES AS IAP BINDING COMPOUNDS Nuevolution A/S (DK) 2011-05-11 EP claimed
WO-2009152824-A1 HETEROCYCLIC DERIVATIVES AS IAP BINDING COMPOUNDS NUEVOLUTION A/S (DK) 2009-12-23 WO claimed
US-4576749-A 3-Acylamino-1-carboxymethylaminocarbonyl-2-azetidinones E. R. SQUIBB & SONS, INC. (US) 1986-03-18 US claimed
EP-0138407-A1 Azetidinones E.R. Squibb &amp; Sons, Inc. (US) 1985-04-24 EP claimed
US-3997528-A BACTERICIDES SHIONOGI & CO., LTD. (JA) 1976-12-14 US claimed
WO-2024151741-A1 MUTANT-SELECTIVE EGFR INHIBITORS DANA-FARBER CANCER INSTITUTE, INC. (US) 2024-07-18 WO disclosed
US-20240116931-A1 PROTEIN KINASE MKK4 INHIBITORS FOR PROMOTING LIVER REGENERATION OR REDUCING OR PREVENTING HEPATOCYTE DEATH HEPAREGENIX GMBH (DE) 2024-04-11 US disclosed
WO-2024006956-A9 DEUBIQUITINASE INHIBITORS AND METHODS OF USE THEREOF DANA-FARBER CANCER INSTITUTE, INC. (US) 2024-04-11 WO disclosed
WO-2024076929-A2 IRREVERSIBLE INACTIVATORS TARGETING ARAF/MEK COMPLEXES DANA-FARBER CANCER INSTITUTE, INC. (US) 2024-04-11 WO disclosed
CN-112424201-B Protein kinase inhibitors that promote liver regeneration or reduce or prevent hepatocyte death 海帕瑞吉尼克斯股份有限公司 2024-04-02 CN disclosed
WO-2024059532-A2 FIRE RETARDANT POLYMERS THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, LAS VEGAS (US) 2024-03-21 WO disclosed
WO-2024046443-A1 MACROCYCLIC COMPOUNDS AS SELECTIVE CDK INHIBITORS NUTSHELL BIOTECH (SHANGHAI) CO., LTD. (CN) 2024-03-07 WO disclosed
US-5770594-A ANTICHOLESTEROL AGENTS, INHIBITORS OF CHOLESTEROL SYNTHESIS PFIZER INC. (US) 1998-06-23 US disclosed
EP-0814080-A1 Squalene synthetase inhibitors PFIZER INC. (US) 1997-12-29 EP disclosed
WO-1997048701-A1 4,1-BENZOXAZEPINES OR 4,1-BENZOTHIAZEPINES AND THEIR USE AS SQUALENE SYNTHETASE INHIBITORS PFIZER INC. (US) 1997-12-24 WO disclosed
WO-1996020184-A1 NAPHTHYL-BENZOXAZEPINES OR -BENZOTHIAZEPINES AS SQUALENE SYNTHETASE INHIBITORS PFIZER INC. (US) 1996-07-04 WO disclosed
US-4576749-A 3-Acylamino-1-carboxymethylaminocarbonyl-2-azetidinones E. R. SQUIBB & SONS, INC. (US) 1986-03-18 US disclosed
EP-0138407-A1 Azetidinones E.R. Squibb &amp; Sons, Inc. (US) 1985-04-24 EP disclosed
US-3997528-A BACTERICIDES SHIONOGI & CO., LTD. (JA) 1976-12-14 US disclosed